Hafnia
HAFN
10.33
+0.20
+1.97%
Hafnia
US · HAFN
#2024 by market cap
Listed 1970
10.33
+0.20
+1.97%
Live - 5344 symbols - heartbeat 199s ago
· 2026-10-08 08:32
Pre-market
10.50
+1.63%
After-hours
10.22
-1.09%
- Market cap
- 5.53B
- P/E (TTM)i
- 7.95
- P/Bi
- 2.09
- EPSi
- 0.67
- Div yieldi
- 7.09%
- 52W posi
- 97%
Reader sentiment
Are you bullish or bearish on HAFN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.54, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -20.45% YoY
Margins
- Gross margin
- 19.20%
- Operating margin
- 15.66%
- Net margin
- 14.89%
Key ratios & quality
- Enterprise valuei
- 6.50B
- Altman Z-Scorei
- 3.54
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 368.39M | 827.86M | 874.10M | 811.22M | 1.93B | 2.67B | 2.87B | 2.28B |
| Gross profit | 42.26M | 181.31M | 239.12M | 35.89M | 840.42M | 852.14M | 849.63M | 438.21M |
| Selling & admin expenses | 4.77M | 14.93M | 24.61M | 28.79M | 37.77M | 42.82M | 50.61M | 50.45M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 19.59M | 146.34M | 206.41M | 78.00K | 797.73M | 801.86M | 777.21M | 357.35M |
| Pretax profit | -19.76M | 72.75M | 151.43M | -51.10M | 758.27M | 799.53M | 778.45M | 342.18M |
| Tax | 24.00K | 1.02M | 2.65M | 4.39M | 6.68M | 6.25M | 4.42M | 2.50M |
| Net profit | -19.78M | 71.73M | 148.78M | -55.49M | 751.59M | 793.28M | 774.04M | 339.68M |
| Basic EPS | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 1 |
| Diluted EPS | -0.06 | 0.21 | 0.41 | -0.15 | 1.54 | 1.56 | 1.50 | 0.67 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- |
| Gross profit | 92.40M | 103.24M | 113.72M | 128.84M | 159.30M | 252.23M |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 75.46M | 83.09M | 98.40M | 100.40M | 150.55M | 240.13M |
| Pretax profit | 64.61M | 78.00M | 92.20M | 107.37M | 180.52M | 279.22M |
| Tax | 1.42M | 2.66M | 699.00K | -2.28M | 788.00K | 1.41M |
| Net profit | 63.19M | 75.34M | 91.50M | 109.65M | 179.73M | 277.80M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 1 |
| Diluted EPS | 0.13 | 0.15 | 0.18 | 0.22 | 0.36 | 0.55 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 139.08M | 334.82M | 280.78M | 372.52M | 874.79M | 932.84M | 900.08M | 843.95M |
| Cash & ST investments | 52.46M | 91.61M | 100.57M | 100.08M | 174.44M | 141.62M | 195.27M | 103.61M |
| Inventory | 22.66M | 6.99M | 5.23M | 70.67M | 89.93M | 107.70M | 94.16M | 69.03M |
| Total assets | 1.31B | 2.68B | 2.54B | 2.54B | 3.95B | 3.91B | 3.70B | 3.81B |
| Total current liabilities | 125.52M | 320.22M | 251.69M | 345.34M | 481.16M | 661.19M | 653.83M | 571.91M |
| Short-term debt | 76.94M | 213.33M | 179.08M | 248.37M | 320.12M | 267.33M | 336.30M | 212.57M |
| Long-term debt | 613.04M | 1.05B | 972.37M | 1.08B | 627.33M | 398.51M | 322.82M | 863.35M |
| Total liabilities | 743,000,000.00 | 1,562,768,000.00 | 1,395,874,000.00 | 1,428,479,000.00 | 1,936,335,000.00 | 1,686,216,000.00 | 1,439,784,000.00 | 1,482,309,000.00 |
| Total equity | 571.08M | 1.12B | 1.15B | 1.11B | 2.01B | 2.23B | 2.26B | 2.33B |
| Retained earnings | -242.38M | -120.92M | -70.46M | -125.96M | 381.89M | 631.03M | 705.18M | 846.22M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 901.26M | 890.42M | 863.85M | 843.95M | 1.13B | 1.09B |
| Cash & ST investments | 188.14M | 194.02M | 132.49M | 103.61M | 146.46M | 270.98M |
| Inventory | 92.29M | 82.31M | 78.23M | 69.03M | 85.68M | 109.75M |
| Total assets | 3.70B | 3.67B | 3.57B | 3.81B | 4.03B | 3.96B |
| Total current liabilities | 724.49M | 738.42M | 569.50M | 571.91M | 708.12M | 659.93M |
| Short-term debt | 373.02M | 395.63M | 224.57M | 212.57M | 246.03M | 231.50M |
| Long-term debt | 270.92M | 238.95M | 555.79M | 863.35M | 734.40M | 610.35M |
| Total liabilities | 1,417,997,000.00 | 1,369,477,000.00 | 1,239,454,000.00 | 1,482,309,000.00 | 1,487,621,000.00 | 1,313,789,000.00 |
| Total equity | 2.28B | 2.30B | 2.33B | 2.33B | 2.54B | 2.65B |
| Retained earnings | 753.74M | 778.52M | 809.77M | 846.22M | 897.76M | 1.03B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 59.67M | 242.83M | 398.47M | 106.44M | 770.89M | 1.06B | 1.03B | 602.89M |
| Depreciation & amortization | 56.87M | 131.51M | 156.44M | 151.68M | 209.22M | 211.03M | 215.11M | 202.13M |
| Free cash flow | 42.42M | -36.19M | 349.88M | 79.41M | 323.51M | 876.41M | 980.74M | 456.69M |
| Dividends paid | 0 | 0 | -98.32M | 0 | -243.75M | -544.14M | -699.88M | -198.64M |
| Stock buybacks / issuance | 46.00M | 71.51M | -12.64M | 0 | 97.78M | 0 | -49.16M | -27.66M |
| Ending cash balance | 52.46M | 91.61M | 100.67M | 100.08M | 280.33M | 222.52M | 283.57M | 192.58M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 137.36M | 187.68M | 118.14M | 159.71M | 127.68M | 298.07M |
| Depreciation & amortization | 49.63M | 51.08M | 52.08M | 49.34M | 48.07M | 47.20M |
| Free cash flow | 110.04M | 146.66M | 74.14M | 125.85M | 106.90M | 277.52M |
| Dividends paid | -14.63M | -50.55M | -60.26M | -73.21M | -88.05M | -143.79M |
| Stock buybacks / issuance | -27.66M | 0 | 0 | 0 | 0 | 0 |
| Ending cash balance | 268.16M | 313.31M | 206.59M | 192.58M | 235.26M | 353.16M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -4.08 | 8.49 | 13.13 | -4.91 | 48.16 | 37.45 | 34.48 | 14.79 |
| ROA %i | -1.56 | 3.59 | 5.69 | -2.20 | 23.38 | 20.26 | 20.33 | 9.04 |
| ROIC %i | 0.51 | 7.01 | 7.68 | -1.02 | 26.89 | 23.34 | 23.46 | 10.99 |
| 5-year avg ROE %i | -- | -4.62 | -4.44 | 2.68 | 12.16 | 20.46 | 25.66 | 25.99 |
| EBIT margin %i | 3.19 | 16.88 | 22.69 | -1.49 | 46.48 | 32.82 | 28.96 | 17.18 |
| FCF / sales %i | 11.52 | -- | 40.03 | 9.79 | 15.39 | 32.80 | 34.19 | 20.01 |
| Current ratioi | 1.11 | 1.05 | 1.12 | 1.08 | 1.82 | 1.41 | 1.38 | 1.48 |
| Quick ratioi | 0.88 | 0.98 | 1.03 | 0.72 | 1.36 | 1.07 | 1.04 | 0.97 |
| Debt / assetsi | 52.51 | 54.01 | 51.39 | 52.40 | 45.00 | 33.02 | 30.31 | 29.46 |
| LT debt / equityi | 107.35 | 110.40 | 98.27 | 97.38 | 72.43 | 46.01 | 34.74 | 39.08 |
| Interest coveragei | 0.37 | 2.09 | 4.23 | -0.31 | 9.10 | 11.33 | 15.86 | 7.88 |
| Revenue CAGR (3Y) %i | 4.08 | 39.91 | 36.13 | 30.10 | 32.52 | 45.13 | 52.35 | 5.80 |
| Net income CAGR (3Y) %i | -- | -- | 268.92 | -- | 118.82 | 74.70 | -- | -23.26 |
| FCF CAGR (3Y) %i | -- | -- | -- | 23.24 | -- | 35.81 | 131.15 | 12.18 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 26.66 | 18.32 | 13.04 | 14.79 | 18.93 | 26.61 |
| ROA %i | 16.27 | 11.43 | 8.37 | 9.04 | 11.81 | 17.26 |
| ROIC %i | 18.91 | 13.58 | 10.29 | 10.99 | 14.20 | 20.13 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 25.56 | 20.77 | 16.42 | 17.18 | 21.03 | 26.43 |
| FCF / sales %i | 32.59 | 30.45 | 23.17 | 20.01 | 18.86 | 21.92 |
| Current ratioi | 1.24 | 1.21 | 1.52 | 1.48 | 1.60 | 1.66 |
| Quick ratioi | 0.99 | 0.90 | 1.11 | 0.97 | 1.16 | 1.34 |
| Debt / assetsi | 28.85 | 27.98 | 25.06 | 29.46 | 25.45 | 22.34 |
| LT debt / equityi | 30.44 | 27.43 | 28.74 | 39.08 | 30.67 | 24.67 |
| Interest coveragei | 13.21 | 9.75 | 7.23 | 7.88 | 10.60 | 15.51 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Medium Range (MR) is the largest reported line at 56.84% of revenue, across 4 reported segments.
- Long Range 1 (LR1) follows at 26.58%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Medium Range (MR)56.84%
Long Range 1 (LR1)26.58%
Handy12.78%
Long Range 2 (LR2)3.80%
Quote time 2026-10-08 08:32:16 · For reference only, not investment advice and not tailored to your situation.